Dermot Kelleher
Director/Board Member at Cellix Ltd.
Dermot Kelleher active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cellix Ltd.
 Cellix Ltd. Medical SpecialtiesHealth Technology Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland. | Director/Board Member | - | - |
| The Institute of Molecular Medicine | Director/Board Member | 2009-09-23 | - |
| University of British Columbia | Corporate Officer/Principal | - | - |
Career history of Dermot Kelleher
Former positions of Dermot Kelleher
| Companies | Position | Start | End |
|---|---|---|---|
| ICON PUBLIC LIMITED COMPANY | Director/Board Member | 2008-04-30 | 2019-07-24 |
| Independent Dir/Board Member | 2008-04-30 | 2019-07-24 | |
| Lee Kong Chian School of Medicine | Corporate Officer/Principal | 2011-12-31 | 2013-12-31 |
| Trinity College Dublin | Corporate Officer/Principal | 2003-12-31 | 2011-12-31 |
| Federation of European Academies of Medicine | President | - | - |
| Imperial College London | Corporate Officer/Principal | - | - |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Founder | 2003-12-31 | - |
Statistics
International
| Ireland | 5 |
| United Kingdom | 2 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| Private companies | 4 |
|---|---|
Cellix Ltd.
Cellix Ltd. Medical SpecialtiesHealth Technology Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
| The Institute of Molecular Medicine | |
| Federation of European Academies of Medicine |
- Stock Market
- Insiders
- Dermot Kelleher
- Experience
